Bionomics Ltd (bno) Logo

Bionomics Ltd (BNO)

___:___ · Healthcare
ASX Delayed
Cboe unavailable

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

BNO ASX Chart

Snapshot

Bionomics Limited (BNO) is a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -83.62%
vs ASX 200 (1yr) -92.01%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,667 of 2,380
Sector Rank 159 of 223

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies AJJ / ATX / MDC
EPS $0.00
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

Please see the Broker Consensus page.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office
Website -
Registry Computershare
Auditor Ernst & Young
Date Listed 21 Dec 1999

Upcoming Calendar (Forecasted)

No calendar entries available.

Former Company Names

  • Bionomics Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

BNO directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
23/02/23 Spyridon Papapetropoulos Issued 27,067,015 $0.029 $784,943 Issue of options
23/02/23 Errol De Souza Issued 10,000,000 $0.029 $290,000 Director remuneration
23/02/23 Errol De Souza Expiry 1,666,667 $0.029 $48,333 Options expired
28/11/22 Alan Fisher Expiry 100,000 $0.066 $6,600 Options expired
28/11/22 Errol De Souza Expiry 100,000 $0.066 $6,600 Options expired
28/11/22 David Wilson Expiry 100,000 $0.066 $6,600 Options expired
12/05/22 Peter Miles Davies Buy +269,984 $0.145 $39,147 As advised by the company
22/12/21 Errol De Souza Issued 61,216,767 $0.115 $7,039,928 Issue of options
20/12/21 Alan Fisher Buy +100,000 $0.120 $12,000 On-market trade
08/04/21 David Wilson Issued 35,990 $0.145 $5,218 Rights issue
23/11/20 Jane Ryan Issued 500,000 $0.125 $62,500 Issue of options
22/10/20 David Wilson Transfer 200,000 $0.130 $26,000 Off-market transfer
22/10/20 David Wilson Transfer 200,000 $0.130 $26,000 Off-market transfer
22/10/20 David Wilson Issued 15,949 $0.040 $638 Rights issue
22/10/20 Peter Turner Issued 15,949 $0.040 $638 Rights issue
28/08/20 Errol De Souza Issued 12,000,000 $0.120 $1,440,000 Issued under employee share plan
18/12/17 Peter Turner Buy +100,000 $0.313 $31,300 Exercise of options
18/12/17 Peter Turner Exercise 100,000 $0.313 $31,300 Exercise of options
08/12/17 Deborah Rathjen Exercise 65,000 $0.285 $18,499 Exercise of options
15/08/17 Deborah Rathjen Expiry 1,000,000 $0.445 $445,000 Options expired
28/11/16 David Wilson Issued 500,000 $0.370 $185,000 Issue of options
28/11/16 Deborah Rathjen Expiry 595,000 $0.370 $220,150 Options expired
28/11/16 Alan Fisher Issued 500,000 $0.370 $185,000 Issue of options
28/11/16 Errol De Souza Issued 500,000 $0.370 $185,000 Issue of options
06/10/16 Errol De Souza Buy +100,000 $0.298 $29,760 Exercise of options
06/10/16 Errol De Souza Exercise 100,000 $0.298 $29,760 Exercise of options
14/09/16 Peter Turner Buy +100,000 $0.289 $28,944 On-market trade
01/09/16 Deborah Rathjen Buy +100,000 $0.247 $24,735 On-market trade
12/08/16 David Wilson Buy +200,000 $0.284 $56,720 On-market trade
30/12/15 Alan Dunton Issued 500,000 $0.365 $182,500 Issue of options
30/12/15 Deborah Rathjen Issued 60,000 $0.365 $21,900 Issue of options
11/12/15 Deborah Rathjen Buy +105,500 $0.390 $41,178 On-market trade
21/10/15 Trevor Tappenden Sell +72,576 $0.531 ($38,502) On-market trade
21/10/15 Trevor Tappenden Exercise 100,000 $0.298 $29,760 Exercise of options
21/10/15 Trevor Tappenden Buy +100,000 $0.298 $29,760 Exercise of options
23/09/15 Errol De Souza Buy +100,000 $0.298 $29,760 Exercise of options
23/09/15 Errol De Souza Sell +80,000 $0.505 ($40,392) On-market trade
23/09/15 Errol De Souza Sell +1,000,000 $0.030 ($29,760) Exercise of options
05/05/15 Deborah Rathjen Exercise 140,000 $0.369 $51,688 Exercise of options
05/05/15 Deborah Rathjen Buy +140,000 $0.369 $51,688 Exercise of options
15/04/15 Deborah Rathjen Buy +190,000 $0.369 $70,148 Exercise of options
15/04/15 Deborah Rathjen Exercise 190,000 $0.369 $70,148 Exercise of options
04/12/14 Deborah Rathjen Buy +20,000 $0.469 $9,371 On-market trade
04/12/14 Deborah Rathjen Issued 75,000 $0.470 $35,250 Employee Share Ownership Plan
21/11/14 Deborah Rathjen Buy +20,000 $0.503 $10,055 On-market trade
17/11/14 Trevor Tappenden Buy +100,000 $0.298 $29,760 Exercise of options
17/11/14 Trevor Tappenden Sell +55,000 $0.544 ($29,899) On-market trade
17/11/14 Trevor Tappenden Exercise 100,000 $0.298 $29,760 Exercise of options
05/11/14 Errol De Souza Expiry 100,000 $0.540 $54,000 Options expired
07/08/14 Deborah Rathjen Expiry 340,000 $0.465 $158,100 Options expired

Director Interests

The current holdings of BNO directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Spyridon Papapetropoulos 23/02/2023 0 N/A 27,067,015 N/A
Errol De Souza 23/02/2023 366,698 N/A 71,950,100 N/A
David Wilson 28/11/2022 251,939 0 400,000 N/A
Alan Fisher 28/11/2022 0 100,000 400,000 N/A
Peter Miles Davies 30/06/2022 269,984 N/A N/A N/A
Jane Ryan 30/06/2022 N/A N/A 500,000 N/A
Aaron Weaver 01/07/2020 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 5, 2022.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Citicorp Nominees Pty Limited <Citibank Ny Adr Dep A/C> 339,875,460 25.11%
HSBC Custody Nominees (Australia) Limited 318,042,650 23.50%
BNP Paribas Nominees Pty Ltd Acf Clearstream 73,460,960 5.43%
BNP Paribas Noms Pty Ltd <DRP> 43,985,676 3.25%
HSBC Custody Nominees (Australia) Limited <Gsco Customers A/C> 34,633,340 2.56%
US Register Control A/C\C 32,409,786 2.39%
Bell Potter Nominees Ltd <Bb Nominees A/C> 28,472,814 2.10%
Citicorp Nominees Pty Limited 20,002,049 1.48%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 17,995,687 1.33%
Merrill Lynch (Australia) Nominees Pty Limited 17,901,124 1.32%
Mr Jason Howard David Camm 9,102,132 0.67%
L&M Group Limited 8,884,085 0.66%
BNP Paribas Noms Pty Ltd <Global Markets Drp> 8,527,043 0.63%
Forward Vision Vii Lp Series 2 6,830,075 0.50%
Mr Mark Richard Potter + Mrs Rebecca Amy Potter <Mark & Rebecca Potter A/C> 5,500,000 0.41%
Charmed5 Pty Ltd 5,000,000 0.37%
Qualvest Pty Ltd <Lin Super Fund A/C> 5,000,000 0.37%
Ambria Investors Lp 4,845,050 0.36%
Provendore Pty Ltd <The Wilks Super Fund A/C> 4,418,550 0.33%
Welas Pty Ltd <The Wales Family Super A/C> 4,403,719 0.33%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Apeiron Presight Capital Fund II LP 05/09/2022 260,550,387 19.90
Apeiron Investment Group Ltd 05/09/2022 260,550,387 19.90
Citigroup Global Markets Australia Pty Limited 23/08/2023 452,849,940 30.83
BVF Partners L.P 22/11/2022 170,089,885 11.58

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
23-08-23 Citigroup Global Markets Australia Pty Limited 29,816,640 28.80 30.83

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.018 30 June
2022 $0.050 30 June
2021 $0.190 30 June
2020 $0.058 30 June
2019 $0.032 28 June
2018 $0.530 29 June
2017 $0.400 28 June
2016 $0.285 28 June
2015 $0.415 30 June
2014 $0.550 30 June
BNO Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.